or
Remember me
Back
PosNeg1 wrote: A phase III cancer immunotherapy program in clinical trials currently and a SP that has been 0.10 or so for several years. Hello? Fate in CEO's hands, I hope not.
Receive investor kits and email updates from Stockhouse and directly from these companies.